ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL1948A |
|
356559-13-2 |
SB-505124 hydrochloride 98+% |
C20H22ClN3O2 | |
CL1270A |
|
924898-09-9 |
Galunisertib monohydrate | LY2157299 monohydrate 98+% |
C22H19N5O.H2O | |
CL2608 |
|
123-78-4 |
D-erythro-Sphingosine | (2S,3R,4E)-2-Amino-4-Octadecene-1,3-Diol | (E,2S,3R)-2-Aminooctadec-4-Ene-1,3-Diol | D-erythro-Sphingosine(DES) 98+% |
C18H37NO2 | |
CL2598 |
|
909910-43-6 |
A 83-01 | A-83-01 98+% |
C25H19N5S | |
CL2440 |
|
133053-19-7 |
Go 6983 98+% |
C26H26N4O3 | |
HL1439 |
|
16837-52-8 |
Oxymatrine 98+% |
C15H24N2O2 | |
CLA1323 |
|
1356922-05-8 |
Bimagrumab (Anti-ACVR2B) 95+% |
— | |
CLA1157 |
|
705287-60-1 |
Stamulumab (Synonyms: MYO-029) 95+% |
— | |
CLA1151 |
|
272780-74-2 |
Metelimumab 95+% |
— | |
CLA1147 |
|
285985-06-0 |
Lerdelimumab 95+% |
— | |
CLA1141 |
|
948564-73-6 |
Fresolimumab 95+% |
— | |
CL2227 |
|
1246304-91-5 |
Roy-Bz 98+% |
C36H38O8 | |
CL2215 |
|
521984-48-5 |
SIS3 HCl 98+% |
C28H28ClN3O3 | |
CL1934 |
|
497259-23-1 |
TPPB (α-Amyloid Precursor Protein Modulator) 98+% |
C27H30F3N3O3 | |
CL1270 |
|
700874-72-2 |
Galunisertib | LY2157299 98+% |
C22H19N5O | |
CL1082 |
|
301836-41-9 |
SB-431542 98+% |
C22H16N4O3 | |
CL1542 |
|
1062368-24-4 |
LDN-193189(DM3189) 98+% |
C25H22N6 | |
CL1057 |
|
1206711-16-1 |
DMH-1 (DMH1) 98+% |
C24H20N4O | |
CL1900 |
|
700874-71-1 |
LY2109761 98+% |
C26H27N5O2 | |
CL1948 |
|
694433-59-5 |
SB-505124 98+% |
C20H21N3O2 | |